This post comes solely from the Cozen O'Connor side of this
blog.
Last week, the Judge in the Testosterone Replacement Therapy
(TRT) MDL threw out an over $140 million jury verdict. In re
Testosterone Replacement Therapy Prods. Liab. Litig. Coordinated
Pretrial Proceedings, 2018 U.S. Dist. LEXIS 111724 (N.D. Ill.
July 5, 2018). It wasn't the first time that the testosterone
MDL court did something like that. Last December, it threw out a
$150 million verdict. That's almost $300 million in verdicts
total. It's got to take some strength to toss such hefty
verdicts—testosterone or not.
In each instance, the court found the jury's verdict to be
so internally inconsistent that it required a new trial. In the
verdict tossed last week, the jury found for the defendants on a
failure to warn claim based in strict liability claim but found for
the plaintiff on a failure to warn claim based in negligence. That
sure does seem inconsistent.